INVESTIGATION OF TALAPOTAKA CHURNA USING FTIR SPECTROSCOPY
DOI:
https://doi.org/10.70066/jahm.v4i3.307Keywords:
Diabetes Mellitus, Ayurveda, Prameha, FTIRAbstract
Diabetes Mellitus, a metabolic syndrome is not new in 21st century but it was widely known problem since
1000 BC and evidence are quite obvious in Ayurveda through its dictation. In 21st century there are many
modern medicines are available but peoples are showing their interest for natural and herbal formulation in
comparison to synthetic medicine due to probable long-term harmful effect. Here, author has selected
Talapotaka Churna, a compound herbal Ayurvedic formulation mentioned in Prameha RogaPrakarana in the
text Vaidya Chintamani for the study. In this scientific era there is a need to validate and standardize the
Ayurvedic formulation. So formulation was studied under Fourier transform Infra-red (FTIR) spectroscopy for
relevant functional group of phytoconstituents present in sample. This study also helpful for projecting a
standard spectrum of ingredients and Talapotaka Churna to minimize batch to batch variation. These
spectrums will be helpful in choosing the accurate raw material by scanning raw material and comparing it
with these spectrums.
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 GURUPRASAD C. NILLE
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.
